Few people outside of research circles know of Battelle Memorial Institute (Battelle), a Columbus, Ohio-based nonprofit research and development organization. But this organization's influence in many fields, including life sciences, is palpable. With a research budget in the several billion dollar range, the organization, which opened up in 1929 and traces its beginnings to industrialist Gordon Battelle, first focused on contract research and development bids supporting metals and materials science. Today, the impact of Battelle’s research impacts a range of sectors from basic science to the commercialization of life science-based therapies, diagnostics and laboratory testing. Active in the fight against COVID-19, Battelle continues to play a critical role in assessing COVID-19 vaccine candidates. For example, Battelle developed a microneutralization assay to analyze the neutralizing response against the virus in human serum samples. Based on a live SARS-CoV-2 virus, this assay is particularly suited for testing samples from vaccine clinical trials.
Go back a year and there were absolutely no assays that existed for SARS-CoV-2, the virus behind COVID-19. Battelle, ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).